Crohn's disease: open trials in South Korea

30 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Inje University Haeundae Paik Hospital, Busan · Kyungpook National University Chilgok Hospital, Daegu · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Inje University Haeundae Paik Hospital, Busan · Yeungnam University Hospital, Daegu · The Catholic University of Korea, Daejeon ST.Mary's Hospital, Daejeon · Kyung Hee University Hospital, Dongdaemun-gu · Seoul National University Bundang Hospital, Seongnam-si · Gangnam Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul · Kangbuk Samsung Hospital, Seoul · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Inje University Haeundae Paik Hospital, Busan · The Catholic University of Korea, Daejeon ST.Mary's Hospital, Daejeon · Samsung Medical Center, Ganggu · Kyung Hee University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Kosin University Gospel Hospital, Busan · Inje University Haeundae Paik Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Asan Medical Center (AMC), Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Korea University Ansan Hospital (Site 3617), Ansan-si · Dong-A University Hospital (Site 3601), Busan · Yeungnam Univeristy Medical Center (Site 3610), Daegu · Kyungpook National Univ.Hospital (Site 3616), Daegu · Keimyung University Dongsan Medical Center (Site 3614), Daegu · The Catholic University of Korea, Daejeon St. Mary's Hospital (Site 3604), Daejeon · Chung-Ang University Hospital (Site 3606), Dongjak-gu · Inje University Haeundae Paik Hospital (Site 3605), Haeundae-gu · Asan Medical Center (Site 3609), Seoul · Kyung Hee University Hospital (Site 3611), Seoul · Kangbuk Samsung Hospital-Internal Medicine (Site 3612), Seoul · Severance Hospital, Yonsei University Health System-Department of Internal Medicine (Site 3603), Seoul · Samsung Medical Center (Site 3613), Seoul · Seoul National University Hospital (Site 3607), Seoul · The Catholic University of Korea, Eunpyeong St. Mary's Hospital (Site 3602), Seoul · The Catholic University Of Korea St. Vincent's Hospital-Gastroenterology (Site 3608), Suwon · Wonju Severance Christian Hospital-Internal Medicine (Site 3600), Wŏnju
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Korea University Ansan Hospital, Ansan-si · Yeungnam University Medical Center, Daegu · Chosun University Hospital, Gwangju · The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul · Hanyang University Seoul Hospital, Seoul
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Ansan-si · Busan · Busan · Daegu · Daejeon · Gwangju · Seoul · Seoul · Seoul · Suwon
Registry updated 2026-10-21
NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Busan · Gwangju · Seoul · Seoul
Registry updated 2026-10-21
NCT05995353
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · AbbVie
Kyungpook National University Chilgok Hospital /ID# 255817, Daegu · Yonsei University Health System - Severance Hospital /ID# 256976, Seoul · Seoul National University Hospital /ID# 255318, Seoul · Samsung Medical Center /ID# 255284, Seoul
Registry updated 2026-10-20
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Dong-A University Hospital, Busan · Inje University Haeundae Paik Hospital, Busan · Kyungpook National University Hospital, Daegu · The Catholic University of Korea, Daejeon ST.Mary's Hospital, Daejeon · Yonsei University Wonju Severance christian hospital, Gangwon-do · Hanyang University Guri Hospital, Guri-si · Samsung Medical Center, Seoul · Kyung Hee University Hospital, Seoul · Seoul National University Hospital, Seoul · Ewha Womans University Hospital (Seoul), Seoul · Chung ang University Hospital, Seoul · Kangbuk Samsung Hospital, Seoul
Registry updated 2026-10-16
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Kyungpook National University Chilgok Hospital, Daegu · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-09
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Kyungpook National University Chilgok Hospital, Deagu · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Inje University Haeundae Paik Hospital, Busan · Kyungpook National University Chilgok Hospital, Daegu · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-07
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Dong-A University Medical Center /ID# 266709, Busan · Inje University Haeundae Paik Hospital /ID# 266380, Busan · Kyungpook National University Chilgok Hospital /ID# 265487, Daegu · The Catholic University of Korea, Daejeon St. Mary's Hospital /ID# 265488, Daejeon · Chungang University Hospital /ID# 266427, Seoul · Samsung Medical Center /ID# 265489, Seoul
Registry updated 2026-09-25
NCT07822087
A Phase 1 Study of ATORM-C in Patients With Crohn's Disease
Trial Treatment · Phase 1 · ORGANOIDSCIENCES LTD.
Asan Medical Center, Seoul
Registry updated 2026-09-16
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Kyungpook National University Chilgok Hospital (KNUCH), Daegu · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-08-03
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Inje University Haeundae Paik Hospital, Busan · Yeungnam University Medical Center, Daegu · The Catholic University of Korea, Daejeon ST.Mary's Hospital, Daejeon · Severance Hospital, Yonsei University Health System, Seoul · Kyung Hee University Hospital, Seoul · Chung ang University Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon
Registry updated 2026-05-27
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Inje University Haeundae Paik Hospital, Haeundae · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-05-22
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Kyungpook National University Chilgok Hospital, Daegu · Gachon University Gil Medical Center, Incheon · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-05-07
NCT04779320
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Kyungpook National University Chilgok Hospital, Daegu · Gachon University Gil Medical Center, Incheon · Seoul National University Hospital, Seongnam · Samsung Medical Center - PPDS, Seoul
Registry updated 2026-05-05
NCT05653011
Predictors of Prognosis in IBD Patients
Research · Seoul National University Bundang Hospital
Seoul National University Bundang Hospital, Seongnam-si
Registry updated 2026-04-24
NCT05428345
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Research · Takeda
Donggguk University Ilsan Hospital, Goyang-si
Registry updated 2025-10-06
NCT07166588
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Research · Seoul National University Hospital
Seoul National University Hospital, Seoul
Registry updated 2025-09-15
NCT07011979
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Research · Seoul National University Hospital
Seoul National University Hospital, Seoul
Registry updated 2025-06-10

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error